ATLANTA, Jan. 05, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will participate in two investor conference events in January.
Mr. Eiswirth will be presenting at the H.C. Wainwright BioConnect 2022 Virtual Conference. The pre-recorded presentation will be accessible to H.C. Wainwright registered attendees beginning at 7:00 AM ET on Monday, January 10, 2022 – January 13, 2022.
Additionally, Mr. Eiswirth will be hosting one-on-one meetings with registered attendees at Bio One-on-One Partnering @ JPM, January 10, 2022 – January 14, 2022.
About Alimera Sciences, Inc.
Alimera Sciences a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.
| For press inquiries: Jules Abraham for Alimera Sciences 917-885-7378 julesa@coreir.com |
For investor inquiries: Scott Gordon for Alimera Sciences scottg@coreir.com |
Experienced Healthcare Executive Brings Extensive Financial and Operational Expertise to Cutera Board of DirectorsBRISBANE, Calif.--(BUSINESS…
Roland Rott, the current president and CEO of Ultrasound, will lead Imaging, replacing Jan Makela…
NEW YORK, June 10, 2024 /PRNewswire/ -- The global glass lens market size is estimated to grow…
NEW YORK, June 10, 2024 /PRNewswire/ -- The global digital pathology market size is estimated to…
Company appoints Pearl Barnett as Chief Operating Officer; Megan Owen becomes Chief Compliance Officer STURGIS,…
MORRISVILLE, N.C., June 10, 2024 /PRNewswire/ -- IEM International, Inc., a global leader in emergency…